Of the 25 biomarkers evaluated, only GM-CSF, SCGF-β, SCF, NGF-β and RANTES were below the level of detection, preventing us from fully assessing the chemokine and growth factor profile in the saliva of stroke patients. The gene discussed is NGF; the disease is Stroke.